Nobuhisa Ishikawa
-
- Lung Cancer Treatments and Mutations 37
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 25
- Chronic Obstructive Pulmonary Disease (COPD) Research 13
- Lung Cancer Diagnosis and Treatment 11
- Neonatal Respiratory Health Research 8
- Oncology top 2%
- Lung Cancer Research Studies 17
- Cancer Research top 5%
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 12
- Immunology top 5%
-
- Asthma and respiratory diseases 8
In The Last Decade
Nobuhisa Ishikawa
119 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 122
- Pulmonary and Respiratory Medicine 2.1k
- Oncology 1.4k
- Cancer Research 627
- Molecular Biology 2.3k
- Immunology 500
Countries citing papers authored by Nobuhisa Ishikawa
This map shows the geographic impact of Nobuhisa Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhisa Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhisa Ishikawa more than expected).
Fields of papers citing papers by Nobuhisa Ishikawa
This network shows the impact of papers produced by Nobuhisa Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhisa Ishikawa. The network helps show where Nobuhisa Ishikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobuhisa Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 0 | |
| 10 | 2014 | 150 | |
| 11 | 2013 | 42 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 2 | |
| 14 | 2011 | 65 | |
| 15 | 2010 | 129 | |
| 16 | 2009 | 211 | |
| 17 | 2007 | 125 | |
| 18 | 2007 | 107 | |
| 19 | 2006 | 112 | |
| 20 | 2005 | 108 |
About Nobuhisa Ishikawa
Nobuhisa Ishikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Internal Medicine, having authored 126 papers that have together received 5.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Lung Cancer Research Studies (17 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Glycosylation and Glycoproteins Research (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Neonatal Respiratory Health Research (8 papers) and Asthma and respiratory diseases (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Oncology (1.4k citations) and Cancer Research (627 citations). Nobuhisa Ishikawa has collaborated with scholars based in Japan, Finland and Germany. Frequent co-authors include Nobuoki Kohno, Noboru Hattori, Yataro Daigo, Eiju Tsuchiya, Akihito Yokoyama, Tatsuya Kato, Atsushi Takano, Tomoo Ito, Kouki Inai and Satoshi Hayama. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.